DrugPatentWatch Database Preview
Sarepta Theraps Inc Company Profile
What is the competitive landscape for SAREPTA THERAPS INC, and what generic alternatives to SAREPTA THERAPS INC drugs are available?
SAREPTA THERAPS INC has one approved drug.
There are five US patents protecting SAREPTA THERAPS INC drugs.
There are one hundred and sixty patent family members on SAREPTA THERAPS INC drugs in twenty-three countries.
Summary for Sarepta Theraps Inc
| International Patents: | 160 |
| US Patents: | 5 |
| Tradenames: | 1 |
| Ingredients: | 1 |
| NDAs: | 1 |
Drugs and US Patents for Sarepta Theraps Inc
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sarepta Theraps Inc | EXONDYS 51 | eteplirsen | SOLUTION;INTRAVENOUS | 206488-002 | Sep 19, 2016 | RX | Yes | Yes | ➤ Sign Up | ➤ Sign Up | |||||
| Sarepta Theraps Inc | EXONDYS 51 | eteplirsen | SOLUTION;INTRAVENOUS | 206488-002 | Sep 19, 2016 | RX | Yes | Yes | 8,486,907 | ➤ Sign Up | Y | ➤ Sign Up | |||
| Sarepta Theraps Inc | EXONDYS 51 | eteplirsen | SOLUTION;INTRAVENOUS | 206488-001 | Sep 19, 2016 | RX | Yes | Yes | 9,243,245 | ➤ Sign Up | Y | ➤ Sign Up | |||
| Sarepta Theraps Inc | EXONDYS 51 | eteplirsen | SOLUTION;INTRAVENOUS | 206488-002 | Sep 19, 2016 | RX | Yes | Yes | 9,416,361 | ➤ Sign Up | Y | ➤ Sign Up | |||
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
International Patents for Sarepta Theraps Inc Drugs
| Country | Document Number | Estimated Expiration |
|---|---|---|
| Japan | 5786109 | ➤ Sign Up |
| Portugal | 2203173 | ➤ Sign Up |
| European Patent Office | 1802777 | ➤ Sign Up |
| Australia | 2006311586 | ➤ Sign Up |
| Country | Document Number | Estimated Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
